According to the most recently released broker notes, 1 analyst has a rating of “strong buy” on the stock, 0 analysts …
The stock last traded at $19.35 just above $18.02, the stock’s 50 day moving average and just below the 200 day …
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Systematic Financial Management Lp reports that it bought 16,970 …
AMAG Pharmaceuticals Inc. AMAG, -2.88% stock surged 4.4% in premarket trade Tuesday after the company said a …
... delay at the Food and Drug Administration could expose Amag Pharmaceuticals (AMAG) to generic competition for a drug meant to prevent preterm birth, but the company's stock overcame a deficit by the close Monday. Previously, the …
Jones has also experienced a tough 2017 with his fund's position in AMAG Pharmaceuticals. The biotech's stock is down around 35% so far this year. AMAG's problems started in January when the company announced its fourth-quarter …
A look at AMAG’s share price movement over the past one year shows that the stock has underperformed the Zacks classified Medical-Biomedical/Genetics industry. Specifically, AMAG’s stock dropped 6.6% during this period, while …
ZACKS6mon
the Board of Directors of AMAG approved awards to Mr. Sanchez of (i) an option to purchase 15,000 shares of common stock and (ii) 2,500 restricted stock units. The option will have an exercise price equal to the closing price of AMAG's …
AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) stock is currently trading at a beat up price, which is nearly 47 percent lower than its 52 weeks high. The company recently announced the commercial launch of its ambitious new product …
Investors in AMAG Pharmaceuticals, Inc. (NASD: AMAG) saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMAG options chain for the new July …